Trials Sponsors Conditions Drugs Pricing

Conditions

Scansys, Pentacam, Keratoconus, Subclinical Keratoconus

Keywords

Scansys, Pentacam, Keratoconus, subclinical keratoconus

Outcome Measures

Primary Outcomes (1)

screening and diagnosis ability
Evaluate the sensitivity and specificity of parameters measured by CASIA2, Pentacam in diagnosing keratoconus using Receiver operating characteristic curves (ROC), and compare the Ectasia Screening Similarity（ESS）and D-value diagnostic efficacy using Area under the ROC curve (AUROC). Use the Delong test to compare the accuracy of various parameters in diagnosing early keratoconus.
one year

Secondary Outcomes (1)

Measurement consistency
one year

Study Arms (3)

Normal control group

Other: Pentacam, Corvis ST and CASIA2

Subclinical keratoconus

Other: Pentacam, Corvis ST and CASIA2

Keratoconus

Other: Pentacam, Corvis ST and CASIA2

Interventions

Pentacam, Corvis ST and CASIA2Other

morphological and biomechanical parameters of corneal were obtain by CASIA2, Pentacam and Corvis ST

KeratoconusNormal control groupSubclinical keratoconus

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients premedicated for refractive surgery

You may qualify if:

Best corrected visual acuity (BCVA) ≥ 20/20;

Sponsors & Collaborators

Tianjin Eye Hospital
Otherlead

Study Sites (1)

Tiajin Eye Hospital

Tianjin, Tianjin Municipality, China

RECRUITING

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

Yan Wang, Prof
Tiajin Eye Hospita
STUDY CHAIR

Central Study Contacts

Shuangcheng Li, Master

CONTACT

022-27313336-7539 lscdoc@163.com

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 30, 2023

First Posted

November 30, 2023

Study Start

July 1, 2023

Actual (reported)

Primary Completion

February 1, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Evolution of a Novel Optical Coherence Tomography Based Index in Diagnosing Keratoconus

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (3)

Normal control group

Subclinical keratoconus

Keratoconus

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (3)

Normal control group

Subclinical keratoconus

Keratoconus

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations